EVAR技术对B型动脉夹层合并感染患者的临床预后效果及主动脉重塑影响的研究

Effect of EVAR on clinical prognosis and aortic remodeling of type Baortic dissection patients complicated with infections

  • 摘要: 目的 探讨B型动脉夹层合并感染患者采用腔内修复术(EVAR)的临床预后效果及对主动脉重塑的影响研究,为临床治疗提供参考依据。方法 选取2013年2月-2016年12月医院诊治的B型动脉夹层合并感染患者117例,根据治疗方式不同分为两组,对照组56例患者采取单纯药物治疗,研究组61例患者采取腔内修复术(EVAR)进行治疗,术后3个月~2年内进行随访,比较两组患者并发症发生情况及病死率,并且通过CT造影术对主动脉重塑情况进行分析。结果 研究组患者并发症发生情况包括内漏发生率8.20%(5/61)、炎性综合征发生率16.39%(10/61)、SG位移发生率1.64%(1/61)、肾功能不全发生率13.11%(8/61)及血栓发生率3.28%(2/61),均低于对照组发生率(均P<0.05); 研究组患者治疗后3个月死亡0例、1年死亡2例(3.28%)、2年死亡4例(6.5%),均低于对照组患者(均P<0.05); 患者治疗后3个月~2年内主动脉真假腔直径均发生改变,与治疗前相比均真腔逐渐增大而假腔逐渐缩小,且研究组变化范围优于对照组患者(均P<0.05)。结论 B型动脉夹层合并感染患者采用EVAR技术,具有安全有效的临床治疗特点,并发症和病死率发生较低,促进主动脉官腔的重塑,对疾病的预后效果有积极的影响作用。

     

    Abstract: OBJECTIVE To explore the effect of endovascular aneurysm repair (EVAR) on clinical prognosis and aortic remodeling of type B aortic dissection patients complicated with infections so as to provide guidance for clinical treatment. METHODS A total of 117 type B aortic dissection patients complicated with infections who were treated in hospitals from Feb 2013 to Dec 2016 were enrolled in the study and divided into two groups according to treatment approach.The control group with 56 cases was given single drug therapy, while the study group with 61 cases was treated with EVAR, the follow-up was conducted after the surgery for 3 months-2 years.The incidence of complications and mortality rate were compared between the two groups of patients, and the status of aortic remodeling was analyzed by means of CT angiography. RESULTS The incidence rates of complications such as endoleak, inflammatory syndrome, SG displacement, renal insufficiency and thrombosis of the study group were respectively 8.20%(5/61), 16.39%(10/61), 1.64%(1/61), 13.11%(8/61) and 3.28%(2/61), significantly lower than those of the control group (all P<0.05).The mortality rate of the study group was 0 (0 case) after the treatment for 3 months, 3.28% (2 cases) after the treatment for 1 year, 6.5% (4 cases) after the treatment for 2 years, significantly lower than that of the control group (all P<0.05).The diameters of both true and false aortic lumens have changed after the treatment for 3 months-2 years, the diameters of true aortic lumens were increased after the treatment, while the diameters of false aortic lumens were decreased after the treatment, and the study group was significantly superior to the control group in the range of variation (all P<0.05). CONCLUSION The EVAR is safe and effective in clinical treatment of the type B aortic dissection patients complicated with infections, facilitates the remodeling of the aortic lumens and has positive effect on the prognosis of the patients, with the incidence of complications and mortality rate low.

     

/

返回文章
返回